retatrutide type 2 diabetes trial 2024 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 A Study of Retatrutide (LY3437943)

Long-term effects unknown : While the clinical trials look good, the long-term safety and efficacy of tirzepatide, especially for weight loss, is still being studied

Phentermine, commonly recognized as an appetite suppressant, is vital in treating obesity by targeting the central nervous system

This makes it relevant to laboratory investigations involving receptor cross-talk, metabolic adaptation, glucose-associated signaling, appetite-associated pathway biology, energy expenditure models, substrate utilization, hepatic metabolic signaling, and adipose-associated response systems

I felt no extra side effects from adding it